In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Renovo Group PLC (scar prevention and wound healing therapeutics) completed its initial public offering on the London Stock Exchange, bringing in gross proceeds of about £57.5mm ($100.5mm). The company sold 66mm shares (including the overallotment) priced at £0.87 apiece.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?